ONVO Organovo Holdings Inc

Price (delayed)

$1.01

Market cap

$10.14M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.17

Enterprise value

$6.2M

Organovo is an early-stage biotechnology company that is developing and utilizing highly customized 3D human tissues as dynamic models of healthy and diseased human biology for drug development. The company's ...

Highlights
ONVO's debt is down by 21% year-on-year and by 6% since the previous quarter
ONVO's gross profit has dropped by 86% year-on-year and by 34% since the previous quarter
The revenue has plunged by 86% YoY and by 34% from the previous quarter

Key stats

What are the main financial stats of ONVO
Market
Shares outstanding
10.04M
Market cap
$10.14M
Enterprise value
$6.2M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.44
Price to sales (P/S)
38.04
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
25.63
Earnings
Revenue
$242,000
EBIT
-$19.08M
EBITDA
-$18.82M
Free cash flow
-$16.92M
Per share
EPS
-$2.17
Free cash flow per share
-$1.86
Book value per share
$0.7
Revenue per share
$0.03
TBVPS
$0.97
Balance sheet
Total assets
$8.88M
Total liabilities
$2.7M
Debt
$1.5M
Equity
$6.18M
Working capital
$4.54M
Liquidity
Debt to equity
0.24
Current ratio
3.67
Quick ratio
3.22
Net debt/EBITDA
0.21
Margins
EBITDA margin
-7,774.8%
Gross margin
100%
Net margin
-7,886.4%
Operating margin
-8,169%
Efficiency
Return on assets
-138.5%
Return on equity
-182.9%
Return on invested capital
-567.7%
Return on capital employed
-265.7%
Return on sales
-7,885.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ONVO stock price

How has the Organovo Holdings stock price performed over time
Intraday
-3.81%
1 week
-1.94%
1 month
3.06%
1 year
-55.51%
YTD
-9.01%
QTD
-9.01%

Financial performance

How have Organovo Holdings's revenue and profit performed over time
Revenue
$242,000
Gross profit
$242,000
Operating income
-$19.77M
Net income
-$19.09M
Gross margin
100%
Net margin
-7,886.4%
ONVO's gross profit has dropped by 86% year-on-year and by 34% since the previous quarter
The revenue has plunged by 86% YoY and by 34% from the previous quarter
The operating income has plunged by 67% YoY
The net income has dropped by 63% year-on-year

Growth

What is Organovo Holdings's growth rate over time

Valuation

What is Organovo Holdings stock price valuation
P/E
N/A
P/B
1.44
P/S
38.04
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
25.63
The EPS has dropped by 62% year-on-year
The equity has dropped by 72% year-on-year and by 27% since the previous quarter
The stock's price to book (P/B) is 15% less than its 5-year quarterly average of 1.7 but 11% more than its last 4 quarters average of 1.3
The revenue has plunged by 86% YoY and by 34% from the previous quarter
The P/S is 2.5% below the last 4 quarters average of 39.0

Efficiency

How efficient is Organovo Holdings business performance
The ROS has dropped by 55% since the previous quarter
The ROE has contracted by 41% from the previous quarter
ONVO's return on assets is down by 32% since the previous quarter
ONVO's return on invested capital is down by 17% since the previous quarter

Dividends

What is ONVO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ONVO.

Financial health

How did Organovo Holdings financials performed over time
ONVO's quick ratio has plunged by 79% YoY and by 34% from the previous quarter
ONVO's current ratio has shrunk by 77% YoY and by 29% QoQ
ONVO's debt is 76% smaller than its equity
The debt to equity has soared by 167% YoY and by 26% from the previous quarter
The equity has dropped by 72% year-on-year and by 27% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.